These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

364 related items for PubMed ID: 17964399

  • 1. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV, Westfield KC, Chalkley TH.
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [Abstract] [Full Text] [Related]

  • 2. Ketorolac versus nepafenac in cataract surgery.
    McCulley JP.
    J Cataract Refract Surg; 2008 Mar; 34(3):345-6; author reply 346. PubMed ID: 18299048
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Effect of topical ketorolac 0.4%, nepafenac 0.1%, and bromfenac 0.09% on postoperative inflammation using laser flare photometry in patients having phacoemulsification.
    Sahu S, Ram J, Bansal R, Pandav SS, Gupta A.
    J Cataract Refract Surg; 2015 Oct; 41(10):2043-8. PubMed ID: 26703278
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of 0.4% ketorolac tromethamine ophthalmic solution versus 0.5% ketorolac tromethamine ophthalmic solution after phacoemulsification and intraocular lens implantation.
    Sandoval HP, De Castro LE, Vroman DT, Solomon KD.
    J Ocul Pharmacol Ther; 2006 Aug; 22(4):251-7. PubMed ID: 16910866
    [Abstract] [Full Text] [Related]

  • 6. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [Abstract] [Full Text] [Related]

  • 7. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Lindstrom R, Holland E, Lane S, Raizman M, Reilly C.
    Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679
    [No Abstract] [Full Text] [Related]

  • 8. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
    Toyos R.
    Cornea; 2008 Apr; 27(3):384; author reply 384-5. PubMed ID: 18362678
    [No Abstract] [Full Text] [Related]

  • 9. Nepafenac 0.1% versus fluorometholone 0.1% for preventing cystoid macular edema after cataract surgery.
    Miyake K, Ota I, Miyake G, Numaga J.
    J Cataract Refract Surg; 2011 Sep; 37(9):1581-8. PubMed ID: 21855758
    [Abstract] [Full Text] [Related]

  • 10. Nepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgery.
    Lane SS, Modi SS, Lehmann RP, Holland EJ.
    J Cataract Refract Surg; 2007 Jan; 33(1):53-8. PubMed ID: 17189793
    [Abstract] [Full Text] [Related]

  • 11. Comparison of prednisolone 1%, rimexolone 1% and ketorolac tromethamine 0.5% after cataract extraction: a prospective, randomized, double-masked study.
    Hirneiss C, Neubauer AS, Kampik A, Schönfeld CL.
    Graefes Arch Clin Exp Ophthalmol; 2005 Aug; 243(8):768-73. PubMed ID: 15756571
    [Abstract] [Full Text] [Related]

  • 12. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR.
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [Abstract] [Full Text] [Related]

  • 13. Nepafenac 0.1% plus dexamethasone 0.1% versus dexamethasone alone: effect on macular swelling after cataract surgery.
    Zaczek A, Artzen D, Laurell CG, Stenevi U, Montan P.
    J Cataract Refract Surg; 2014 Sep; 40(9):1498-505. PubMed ID: 25135542
    [Abstract] [Full Text] [Related]

  • 14. Prostaglandin E2 inhibition and aqueous concentration of ketorolac 0.4% (acular LS) and nepafenac 0.1% (nevanac) in patients undergoing phacoemulsification.
    Bucci FA, Waterbury LD, Amico LM.
    Am J Ophthalmol; 2007 Jul; 144(1):146-7. PubMed ID: 17601444
    [Abstract] [Full Text] [Related]

  • 15. A randomized comparison of to-aqueous penetration of ketorolac 0.45%, bromfenac 0.09% and nepafenac 0.1% in cataract patients undergoing phacoemulsification.
    Bucci FA, Waterbury LD.
    Curr Med Res Opin; 2011 Dec; 27(12):2235-9. PubMed ID: 21992076
    [Abstract] [Full Text] [Related]

  • 16. A randomized double-masked trial comparing ketorolac tromethamine 0.5%, diclofenac sodium 0.1%, and prednisolone acetate 1% in reducing post-phacoemulsification flare and cells.
    el-Harazi SM, Ruiz RS, Feldman RM, Villanueva G, Chuang AZ.
    Ophthalmic Surg Lasers; 1998 Jul; 29(7):539-44. PubMed ID: 9674003
    [Abstract] [Full Text] [Related]

  • 17. A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients.
    Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LS for Cystoid Macular Edema (ACME) Study Group.
    Am J Ophthalmol; 2008 Oct; 146(4):554-560. PubMed ID: 18599019
    [Abstract] [Full Text] [Related]

  • 18. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA.
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [Abstract] [Full Text] [Related]

  • 19. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
    Durrie DS, Kennard MG, Boghossian AJ.
    Adv Ther; 2007 Sep; 24(6):1278-85. PubMed ID: 18165210
    [Abstract] [Full Text] [Related]

  • 20. Comparison of ketorolac tromethamine 0.5% and rimexolone 1% to control inflammation after cataract extraction. Prospective randomized double-masked study.
    Solomon KD, Vroman DT, Barker D, Gehlken J.
    J Cataract Refract Surg; 2001 Aug; 27(8):1232-7. PubMed ID: 11524195
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.